Preclinical pharmacology and toxicology studies
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261200433007C
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,677,699
Award facts
- Contract value 20% obligated
-
- $20,302,301.83 Current, with exercised options
- $23,192,206.83 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$637,495 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $271,118 | |
| Supplemental Agreement for work within scope | $415,449 | |
| Funding Only Action | $1,001,320 | |
| Funding Only Action | $93,585 | |
| Funding Only Action | $945,000 | |
| Funding Only Action | $850,000 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $887,375 | |
| Original award | $851,347 |
Show all 13
About this award
This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Southern Research Institute, a non-profit research organization. The contract, valued at $23,192,206.83, is for preclinical pharmacology and toxicology studies. It does not have a set-aside designation. Southern Research Institute has a history of providing a range of research and development services to federal agencies, including drug discovery and development work for the NIH. This contract award is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle that Southern Research holds to provide preclinical services for the development of HIV therapeutics, antimicrobials, and other emerging therapeutics.
Quick answers
Who was awarded contract HHSN261200433007C?
HHSN261200433007C was awarded to Southern Research Institute by National Cancer Institute (National Institutes of Health) on June 1, 2004.
How much is contract HHSN261200433007C worth?
The government has obligated $4,677,699 on HHSN261200433007C. Its current value, with exercised options, is $20,302,302. Its potential value, with all options, is $23,192,207.
Was contract HHSN261200433007C competed?
The extent of competition for HHSN261200433007C was full and open competition. The government received 8 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award